Biotechnology Services

Tempest Therapeutics’ inventory jumps 1,900% as liver-cancer remedy exhibits promise

Amgen to proceed to hunt full approval of Lumakras most cancers drug after FDA panel votes in opposition to it

Moderna reviews constructive outcomes for mixture flu and COVID vaccine

PayPal and Dropbox shares fall after downgrades, GM shares inch greater, and extra shares on the transfer

As Medicare drug-price negotiations inch ahead, some states are flexing new powers to chop prices for a broader swath of medication 

Can Nvidia continue to grow so shortly? Here’s what Wall Street thinks.

As COVID hospitalizations rise, Pfizer and Moderna say up to date pictures present promise in opposition to Eris variant

FDA approves first-ever tablet for postpartum melancholy in new moms

Here are the 20 finest performing shares of March — and the 20 worst

Sartorius, Sartorius Stedim shares fall after Polyplus acquisition